Cargando…
Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine
The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pl...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303842/ https://www.ncbi.nlm.nih.gov/pubmed/25569626 http://dx.doi.org/10.3390/nu7010321 |
_version_ | 1782353983326650368 |
---|---|
author | Ahmad, Aamir Ginnebaugh, Kevin R. Li, Yiwei Padhye, Subhash B. Sarkar, Fazlul H. |
author_facet | Ahmad, Aamir Ginnebaugh, Kevin R. Li, Yiwei Padhye, Subhash B. Sarkar, Fazlul H. |
author_sort | Ahmad, Aamir |
collection | PubMed |
description | The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pleiotropic effects and the ability to modulate multiple signaling pathways, which is a good attribute of natural agents, nutraceuticals have frequently been demonstrated to re-sensitize drug-resistant cancers. The effectiveness of nutraceuticals can be further enhanced if the tools for the relative assessment of their molecular targets are readily available. Such information can be critical for determining their most effective uses. Here, we discuss the anticancer potential of nutraceuticals and the associated challenges that have interfered with their translational potential as a naturopathic approach for the management of cancers. In the years to come, an efficient screening and assessment of molecular targets will be the key to make rapid progress in the area of drug design and discovery, especially focusing on evidence-based development of naturopathy for the treatment of human malignancies. |
format | Online Article Text |
id | pubmed-4303842 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-43038422015-02-02 Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine Ahmad, Aamir Ginnebaugh, Kevin R. Li, Yiwei Padhye, Subhash B. Sarkar, Fazlul H. Nutrients Review The relevance of naturopathy (defined as the practice of medicine for the treatment of human diseases with natural agents) in human cancer is beginning to be appreciated, as documented by renewed interest in nutraceutical research, the natural anticancer agents of dietary origin. Because of their pleiotropic effects and the ability to modulate multiple signaling pathways, which is a good attribute of natural agents, nutraceuticals have frequently been demonstrated to re-sensitize drug-resistant cancers. The effectiveness of nutraceuticals can be further enhanced if the tools for the relative assessment of their molecular targets are readily available. Such information can be critical for determining their most effective uses. Here, we discuss the anticancer potential of nutraceuticals and the associated challenges that have interfered with their translational potential as a naturopathic approach for the management of cancers. In the years to come, an efficient screening and assessment of molecular targets will be the key to make rapid progress in the area of drug design and discovery, especially focusing on evidence-based development of naturopathy for the treatment of human malignancies. MDPI 2015-01-06 /pmc/articles/PMC4303842/ /pubmed/25569626 http://dx.doi.org/10.3390/nu7010321 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ahmad, Aamir Ginnebaugh, Kevin R. Li, Yiwei Padhye, Subhash B. Sarkar, Fazlul H. Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title | Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title_full | Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title_fullStr | Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title_full_unstemmed | Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title_short | Molecular Targets of Naturopathy in Cancer Research: Bridge to Modern Medicine |
title_sort | molecular targets of naturopathy in cancer research: bridge to modern medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303842/ https://www.ncbi.nlm.nih.gov/pubmed/25569626 http://dx.doi.org/10.3390/nu7010321 |
work_keys_str_mv | AT ahmadaamir moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine AT ginnebaughkevinr moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine AT liyiwei moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine AT padhyesubhashb moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine AT sarkarfazlulh moleculartargetsofnaturopathyincancerresearchbridgetomodernmedicine |